Nuzenio

Beone Medicines

Beone Medicines news intelligence with latest source-attributed stories, timeline, related explainers, connected entities, source diversity, and FAQ.

topic 24 latest news signals 11 publisher sources 100/100 entity strength

Latest news

Timeline

Sat, 08 Aug 2026 16:57:00 GMTBeOne Medicines Ltd. Stock 12‑Month Price Target Raised to $419.74, Implies 30% Upside - TradingView
Sat, 08 Aug 2026 07:41:42 GMTDimensional Fund Advisors LP Raises Position in BeOne Medicines Ltd. - Sponsored ADR $ONC - MarketBeat
Fri, 07 Aug 2026 18:44:50 GMTJohn V. Oyler Highlights BeOne Medicines’ Strong Q2 2026 Results - Oncodaily
Fri, 07 Aug 2026 04:01:30 GMTBeOne Medicines (ONC) Earnings Beat And Higher Guidance Leave Valuation In Focus - simplywall.st
Fri, 07 Aug 2026 00:18:00 GMTIs BeOne Medicines (ONC) Undervalued Following Its Earnings Beat And Raised Outlook? - Yahoo Finance
Thu, 06 Aug 2026 19:54:24 GMTBeOne Medicines (NASDAQ:ONC) Given New $454.00 Price Target at TD Cowen - MarketBeat

FAQ

What does this page track?

Latest RSS headlines, source names, timestamps, related explainers, connected entities, and timeline signals for Beone Medicines.

Why might this page be noindex?

Nuzenio only indexes entity pages after enough useful source-attributed coverage and source diversity exists.

Where should readers verify facts?

Open the original publisher links from each story for full reporting, quotes, figures, images, corrections, and updates.

Source diversity

11 distinct publisher/source names are currently connected to this entity page.